Form 4 for TBPH Theravance Biopharma, Inc.
Accepted 2023-08-24 00:00:00 ET · period of report 2023-08-22 · accession 0001415889-23-012621 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-24 | 2023-08-22 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $9.47 | -1,807 | 340.6K | -0.5% | -$17.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-08-22 | S | D | 1,807 | $9.47 | 340,566 | D | — | — | (F1) This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/09/2023. |